Quantifying the incidence of severe-febrile-illness hospital admissions in sub-Saharan Africa

Paul Roddy, Ursula Dalrymple, Tomas O Jensen, Sabine Dittrich, V Bhargavi Rao, Daniel A Pfeffer, Katherine A Twohig, Teri Roberts, Oscar Bernal, Ethan Guillen, Paul Roddy, Ursula Dalrymple, Tomas O Jensen, Sabine Dittrich, V Bhargavi Rao, Daniel A Pfeffer, Katherine A Twohig, Teri Roberts, Oscar Bernal, Ethan Guillen

Abstract

Severe-febrile-illness (SFI) is a common cause of morbidity and mortality across sub-Saharan Africa (SSA). The burden of SFI in SSA is currently unknown and its estimation is fraught with challenges. This is due to a lack of diagnostic capacity for SFI in SSA, and thus a dearth of baseline data on the underlying etiology of SFI cases and scant SFI-specific causative-agent prevalence data. To highlight the public health significance of SFI in SSA, we developed a Bayesian model to quantify the incidence of SFI hospital admissions in SSA. Our estimates indicate a mean population-weighted SFI-inpatient-admission incidence rate of 18.4 (6.8-31.1, 68% CrI) per 1000 people for the year 2014, across all ages within areas of SSA with stable Plasmodium falciparum transmission. We further estimated a total of 16,200,337 (5,993,249-27,321,779, 68% CrI) SFI hospital admissions. This analysis reveals the significant burden of SFI in hospitals in SSA, but also highlights the paucity of pathogen-specific prevalence and incidence data for SFI in SSA. Future improvements in pathogen-specific diagnostics for causative agents of SFI will increase the abundance of SFI-specific prevalence and incidence data, aid future estimations of SFI burden, and enable clinicians to identify SFI-specific pathogens, administer appropriate treatment and management, and facilitate appropriate antibiotic use.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Final fitted relationship between incidence…
Fig 1. Final fitted relationship between incidence of IPD admissions for severe-febrile-illness (all ages) and estimated prevalence of community-acquired febrile illness (
The median of the final fitted relationship is represented by the black line, with 68% and 95% credible intervals overlain in increasingly light grey. The overlain points are the observations of the 45 country-years of the incidence of severe-febrile-illness (all ages) versus the national estimated prevalence of community-acquired fever (

Fig 2. Incidence rate (per 1000 people)…

Fig 2. Incidence rate (per 1000 people) of SFI-IPD admissions for severe-febrile-illness in 2014 for…

Fig 2. Incidence rate (per 1000 people) of SFI-IPD admissions for severe-febrile-illness in 2014 for each sub-Saharan African country within areas of stable P. falciparum malaria transmission.

Fig 3. Incidence rate (per 1000 people)…

Fig 3. Incidence rate (per 1000 people) of 2014 IPD admissions for severe-febrile-illness due to…

Fig 3. Incidence rate (per 1000 people) of 2014 IPD admissions for severe-febrile-illness due to all illnesses other than severe malaria (but including admissions for uncomplicated malaria) for each sub-Saharan African country within areas of stable P. falciparum transmission.
Estimates for severe malaria IPD admissions were unavailable for Equatorial Guinea, South Africa, South Sudan, and eSwatini, thus these countries were not included in this section of the analysis.

Fig 4. Incidence rate (per 1000 people)…

Fig 4. Incidence rate (per 1000 people) of 2014 IPD admissions for severe malaria (not…

Fig 4. Incidence rate (per 1000 people) of 2014 IPD admissions for severe malaria (not including uncomplicated malaria) for each sub-Saharan African country within areas of stable P. falciparum malaria transmission.
These estimates were produced by Camponovo et al. [46]. Estimates for severe malaria IPD admissions were unavailable for Equatorial Guinea, South Africa, South Sudan, and eSwatini, thus these countries were not included in this section of the analysis.

Fig 5. The proportion of 2014 IPD…

Fig 5. The proportion of 2014 IPD admissions for severe-febrile-illness that were causally due to…

Fig 5. The proportion of 2014 IPD admissions for severe-febrile-illness that were causally due to illnesses other than severe malaria for each sub-Saharan African country within areas of stable P. falciparum transmission.
Illnesses other than severe malaria include admissions for uncomplicated malaria. Estimates for severe malaria IPD admissions were unavailable for Equatorial Guinea, South Africa, South Sudan, and eSwatini, thus these countries were not included in this section of the analysis.
Fig 2. Incidence rate (per 1000 people)…
Fig 2. Incidence rate (per 1000 people) of SFI-IPD admissions for severe-febrile-illness in 2014 for each sub-Saharan African country within areas of stable P. falciparum malaria transmission.
Fig 3. Incidence rate (per 1000 people)…
Fig 3. Incidence rate (per 1000 people) of 2014 IPD admissions for severe-febrile-illness due to all illnesses other than severe malaria (but including admissions for uncomplicated malaria) for each sub-Saharan African country within areas of stable P. falciparum transmission.
Estimates for severe malaria IPD admissions were unavailable for Equatorial Guinea, South Africa, South Sudan, and eSwatini, thus these countries were not included in this section of the analysis.
Fig 4. Incidence rate (per 1000 people)…
Fig 4. Incidence rate (per 1000 people) of 2014 IPD admissions for severe malaria (not including uncomplicated malaria) for each sub-Saharan African country within areas of stable P. falciparum malaria transmission.
These estimates were produced by Camponovo et al. [46]. Estimates for severe malaria IPD admissions were unavailable for Equatorial Guinea, South Africa, South Sudan, and eSwatini, thus these countries were not included in this section of the analysis.
Fig 5. The proportion of 2014 IPD…
Fig 5. The proportion of 2014 IPD admissions for severe-febrile-illness that were causally due to illnesses other than severe malaria for each sub-Saharan African country within areas of stable P. falciparum transmission.
Illnesses other than severe malaria include admissions for uncomplicated malaria. Estimates for severe malaria IPD admissions were unavailable for Equatorial Guinea, South Africa, South Sudan, and eSwatini, thus these countries were not included in this section of the analysis.

References

    1. Maze MJ, Bassat Q, Feasey NA, Mandomando I, Musicha P, Crump JA. The epidemiology of febrile illness in sub-Saharan Africa: implications for diagnosis and management. Clinical Microbiology and Infection. Volume 24, Issue 8, August 2018, Pages 808–814. 10.1016/j.cmi.2018.02.011.
    1. Crump JA, Kirk MD (2015). Estimating the Burden of Febrile Illness. PLoS Neglected Tropical Diseases. 9(12): e0004040 10.1371/journal.pntd.0004040
    1. Prasad N, Sharples KJ, Murdoch DR, Crump JA. Community Prevalence of Fever and Relationship with Malaria among Infants and Children in Low-Resource Areas. The American Journal of Tropical Medicine and Hygiene. 2015. 93(1), pp. 178–180. 10.4269/ajtmh.14-0646
    1. Feikin DR, Scott JA, Gessner BD. Use of vaccines as probes to define disease burden. The Lancet. 2014;383:1762–70. .
    1. Biritwum RB, Welbeck J, Barnish G. Incidence and management of malaria in two communities of different socio-economic level, in Accra, Ghana. Annals of Tropical Medicine & Parasitology. 2000;94(8):771–8.
    1. Nonvignon J, Chinbuah MA, Gyapong M, Abbey M, Awini E, Gyapong JO, Aikins M. Is home management of fevers a cost-effective way of reducing under-five mortality in Africa? The case of a rural Ghanaian District. Tropical Medicine & International Health. 2012;17(8):951–7.
    1. Stoler and Awandare. Febrile illness diagnostics and the malaria-industrial complex: a socio-environmental perspective. BMC Infectious Diseases. 2016. 16:683 10.1186/s12879-016-2025-x
    1. Dalrymple U, Cameron E, Bhatt S, Weiss DJ, Gupta S, Gething PW. Quantifying the contribution of Plasmodium falciparum malaria to febrile illness amongst African children. eLife. 2017;6:e29198 10.7554/eLife.29198
    1. Ahorlu CK, Dunyo SK, Afari EA, Koram KA, Nkrumah FK. Malaria-related beliefs and behaviour in southern Ghana: implications for treatment, prevention and control. Tropical Medicine & International Health. 1997;2(5):488–99.
    1. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 8 October 2015; Volume 526, pages 207–211.
    1. Crump JA, Morrissey AB, Nicholson WL, Massung RF, Stoddard RA, Galloway RL, et al. Etiology of severe nonmalaria febrile illness in Northern Tanzania: a prospective cohort study. PLoS Neglected Tropical Diseases. 2013;7(7):e2324 10.1371/journal.pntd.0002324
    1. Bisoffi Z, Buonfrate D. When fever is not malaria. Lancet Global Health. 2013;1(1):e11–2. 10.1016/S2214-109X(13)70013-5
    1. Chandler C, Jones C, Boniface G, Juma K, Reyburn H, Whitty C. Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study. Malaria Journal. 2008;7:53 10.1186/1475-2875-7-53
    1. Chandler C, Mwangi R, Mbakilwa H, Olomi R, Whitty CJM, Reyburn H. Malaria overdiagnosis: is patient pressure the problem? Health Policy and Planning. 2008; 23(3):170–8. 10.1093/heapol/czm046
    1. Font F, Alonso Gonzalez M, Nathan R, Kimario J, Lwilla F, Ascaso C, et al. Diagnostic accuracy and case management of clinical malaria in the primary health services of a rural area in south-eastern Tanzania. Tropical Medicine & International Health. 2001;6:423–8.
    1. Koram KA, Molyneux ME. When is “malaria” malaria? The different burdens of malaria infection, malaria disease, and malaria-like illnesses. The American Journal of Tropical Medicine and Hygiene. 2007;77(6 Suppl):1–5.
    1. Nankabirwa J, Zurovac D, Njogu J, Rwakimari J, Counihan H, Snow R, Tibenderana J. Malaria misdiagnosis in Uganda—implications for policy change. Malaria Journal. 2009;8(1):66.
    1. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al. Overdiagnosis of malaria inpatients with severe febrile illness in Tanzania: a prospective study. BMJ. 2004;329(7476):1212 10.1136/bmj.38251.658229.55
    1. Van Dillen J, De Jager A, De Jong I, Wendte J. Overdiagnosis of malaria in hospitalized patients in Namibia. Tropical Doctor. 2007;37:185–6. 10.1258/004947507781524845
    1. Ye Y, Madise N, Ndugwa R, Ochola S, Snow RW. Fever treatment in the absence of malaria transmission in an urban informal settlement in Nairobi, Kenya. Malaria Journal. 2009;8:160 10.1186/1475-2875-8-160
    1. Amexo M, Tolhurst R, Barnish G, Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. The Lancet. 2004;364(9448):1896–8.
    1. Nankabirwa J, Zurovac D, Njogu J, Rwakimari J, Counihan H, Snow R, Tibenderana J. Malaria misdiagnosis in Uganda—implications for policy change. Malaria Journal. 2009;8(1):66.
    1. Chandramohan D, Jaffar S, Greenwood B. Use of clinical algorithms for diagnosing malaria. Tropical Medicine & International Health. 2002;7(1):45–52.
    1. Baba MM, Saron M-F, Vance VA, Adeniji JA, Diop O, Olaleye D. Dengue virus infections in patients suspected of malaria/typhoid in Nigeria. The Journal of American Science. 2009;5(5):129–34.
    1. O’Dempsey TJD, McArdle TF, Laurence BE, Lamont AC, Todd JE, Greenwood BM. Overlap in the clinical features of pneumonia and malaria in African children. Transactions of the Royal Society of Tropical Medicine & Hygiene. 1993;87(6):662–5.
    1. World Health Organization. 2017. World Malaria Report 2017. Geneva, Switzerland: World Health Organization. . [Accessed 27 February 2019].
    1. Oladosu OO, Oyibo WA. Overdiagnosis and overtreatment of malaria in children that presented with fever in Lagos, Nigeria. ISRN Infectious Diseases. 2013. 2013:6.
    1. World Health Organization. 2014. World Malaria Report 2014. Geneva, Switzerland: World Health Organization. . [Accessed 27 February 2019].
    1. President’s Malaria Initiative. Ghana Malaria Operational Plan FY 2014. Washington, DC: President’s Malaria Initiative; 2014. . [Accessed 27 February 2019].
    1. Malm K, Bart-Plange C, Armah G, Gyapong J, Owusu-Adjei S, Koram K, Binka F. Malaria as a cause of acute febrile illness in an urban paediatric population in Ghana. In: Proceedings of the Annual Meeting of the American Society of Tropical Medicine and Hygiene: November 11–15 2012. Atlanta: American Society of Tropical Medicine and Hygiene; 2012. . [Accessed 27 February 2019].
    1. Prasad N, Murdoch DR, Reyburn H, Crump JA. Etiology of Severe Febrile Illness in Low- and Middle-Income Countries: A Systematic Review. PLoS ONE. 2015. 10(6): e0127962 10.1371/journal.pone.0127962
    1. Penno EC, Baird SJ, Crump JA. Cost-Effectiveness of Surveillance for Bloodstream Infections for Sepsis Management in Low-Resource Settings. The American Journal of Tropical Medicine and Hygiene. 2015, October 7; 93(4): 850–860. 10.4269/ajtmh.15-0083
    1. Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infectious Diseases. 2010. 10(6): 417–432. 10.1016/S1473-3099(10)70072-4
    1. Seale AC, Blencowe H, Manu AA, Nair H, Bahl R, Qazi SA, et al. Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2014; 14: 731–41. 10.1016/S1473-3099(14)70804-7
    1. World Health Organization. A Multiplex Multi-Analyte Diagnostic Platform. . [Accessed 27 February 2019].
    1. Nkengasong JN, Yao K, Onyebujoh P. Laboratory medicine in low-income and middle-income countries: progress and challenges. The Lancet. May 12, 2018 391;10133, pp1873-1875.10.1016/S0140-6736(18)30308-8. Available at: . [Accessed 27 February 2019].
    1. Dailey PJ, Osborn J, Ashley EA, Baron EJ, Dance DAB, Fusco D, et al. Defining System Requirements for Simplified Blood Culture to Enable Widespread Use in Resource-Limited Settings. Diagnostics. 2019,9(1),10 10.3390/diagnostics9010010. Available at: . [Accessed 27 February 2019].
    1. Ombelet S, Ronat JB, Walsh T, Yansouni CP, Cox J, Vlieghe E, et al. Clinical bacteriology in low-resource settings: today´s solutions. The Lancet Infectious Diseases. August 1, 2018. 18(8);PE248–E258.10.1016/S1473-3099(18)30093-8. Available at: . [Accessed 27 February 2019].
    1. Loonen AJM, de Jager CPC, Tosserams J, Kusters R, Hilbink M, Wever PC, van den Brule AJC. Biomarkers and Molecular Analysis to Improve Bloodstream Infection Diagnostics in an Emergency Care Unit. PLoS ONE. 9(1): e87315 10.1371/journal.pone.0087315. Available at: . [Accessed 27 February 2019]
    1. London School of Hygiene and Tropical Medicine. Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE). . [Accessed 27 February 2019].
    1. United Nations, Department of Economic and Social Affairs, Population Division (2017). World Population Prospects: The 2017 Revision, Key Findings and Advance Tables. Working Paper No. ESA/P/WP/248. . [Accessed 27 February 2019].
    1. Kristensen K, Nielsen A, Berg CW, Skaug H, Bell BM. TMB: Automatic Differentiation and Laplace Approximation. Journal of Statistical Software. 2016. 17;5 Available at: . [Accessed 27 February 2019].
    1. Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, Hay SI, Snow RW. The Limits and Intensity of Plasmodium falciparum Transmission: Implications for Malaria Control and Elimination Worldwide. PLoS Medicine. 2008. 5(2): e38 Available at: . [Accessed 27 February 2019]
    1. Worldpop. Worldpop: High resolution age-structured population distribution maps. . [Accessed 27 February 2019].
    1. Sigauque B, Roca A, Mandomando I, Morais L, Quinto L, Sacarlal J, et al. Community-Acquired Bacteremia Among Children Admitted to a Rural Hospital in Mozambique. The Pediatric Infectious Disease Journal. 2009. 28(2): 108–113. 10.1097/INF.0b013e318187a87d
    1. Camponovo F, Bever CA, Galactionova K, Smith T, Denny MA. Incidence and admission rates for severe malaria and their impact on mortality in Africa. Malaria Journal. 2017. 16:1 10.1186/s12936-016-1650-6

Source: PubMed

3
Subscribe